Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: Results of the EPISTENT (Evaluation of Platelet IIb/ IIIa Inhibitor for Stenting Trial) diabetic substudy - Marso, SP; Lincoff, AM; Ellis, SG; Bhatt, DL; Tanguay, JF; Kleiman, NS (Circulation, 1999)